Home › Acute Myeloid Leukemia › California › Santa Rosa
Acute Myeloid Leukemia clinical trials in Santa Rosa, CA
3 studies for Acute Myeloid Leukemia are looking for participants at sites in and around Santa Rosa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- Kaiser Permanente-Santa Rosa, Santa Rosa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Providence Medical Foundation - Santa Rosa, Santa Rosa
- Providence Santa Rosa Memorial Hospital, Santa Rosa
- Saint Helena Hospital, St. Helena · 14 mi away
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- Kaiser Permanente-Santa Rosa, Santa Rosa
About Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML) is a cancer of the white blood cells. AML usually gets worse quickly if it is not treated. Read more.
More about Acute Myeloid Leukemia on MedlinePlus
Acute Myeloid Leukemia trials in other cities
- Houston, TX85 studies
- New York City, NY51 studies
- Boston, MA44 studies
- Seattle, WA41 studies
- Baldwin Park, CA40 studies
- Columbus, OH35 studies
- Philadelphia, PA34 studies
- Durham, NC33 studies
- Atlanta, GA31 studies
- Tampa, FL29 studies
- Chicago, IL26 studies
- Portland, OR25 studies
Other studies in Santa Rosa
- Non-Small Cell Lung Cancer17 studies
- Lung Cancer11 studies
- Cancer (all types)11 studies
- Breast Cancer11 studies
- Colorectal Cancer11 studies
- Metastatic Cancer9 studies
- Prostate Cancer9 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer6 studies
- Endometrial Cancer6 studies
- Colon Cancer5 studies
- Stomach Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.